Pediatric Pharmacokinetics Human Development and Drug Disposition

被引:35
|
作者
Funk, Ryan S. [1 ]
Brown, Jacob T. [1 ]
Abdel-Rahman, Susan M. [1 ,2 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Med Toxicol, Kansas City, MO 64108 USA
[2] Univ Missouri, Dept Pediat, Sch Med, Kansas City, MO 64108 USA
关键词
Pediatric; Pharmacokinetic; Development; Absorption; Distribution; Metabolism; Excretion; Transport; SINGLE-DOSE PHARMACOKINETICS; PLASMA-PROTEIN BINDING; AGE-RELATED-CHANGES; TISSUE DISTRIBUTION; HUMAN LIVER; POPULATION PHARMACOKINETICS; INTRAVENOUS OMEPRAZOLE; HEALTHY-VOLUNTEERS; PRETERM INFANTS; SMALL-INTESTINE;
D O I
10.1016/j.pcl.2012.07.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Human development is described by the various anatomic and physiologic changes that occur as the single-celled zygote matures into an adult human being. Concomitant with bodily maturation are changes in the complex interactions between pharmacologic agents and the biologic matrix that is the human body. Profound changes in the manner by which drugs traverse the body during development can have significant implications in drug efficacy and toxicity. Although not a replacement for well-conducted, pediatric, pharmacokinetic studies, an understanding of developmental biology and the mechanisms for drug disposition invariably assists the pediatric clinician with the judicious use of medications in children.
引用
收藏
页码:1001 / +
页数:17
相关论文
共 50 条
  • [21] The development of models for the evaluation of pulmonary drug disposition
    Liu, Xin
    Jin, Lu
    Upham, John W.
    Roberts, Michael S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (04) : 487 - 505
  • [22] Absorption, Disposition and Pharmacokinetics of Solid Lipid Nanoparticles
    Qi, Jianping
    Lu, Yi
    Wu, Wei
    CURRENT DRUG METABOLISM, 2012, 13 (04) : 418 - 428
  • [23] Disposition Pathways and Pharmacokinetics of Herbal Medicines in Humans
    He, S. -M.
    Li, C. G.
    Liu, J. -P.
    Chan, E.
    Duan, W.
    Zhou, S. -F.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (33) : 4072 - 4113
  • [24] Pediatric Renal Ontogeny and Applications in Drug Development
    Zhang, Yifei
    Mehta, Neha
    Muhari-Stark, Edit
    Burckart, Gilbert J.
    Van Den Anker, John
    Wang, Jian
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 : S9 - S20
  • [25] Optimizing drug therapy in pediatric SCT: Focus on pharmacokinetics
    McCune, J. S.
    Jacobson, P.
    Wiseman, A.
    Militano, O.
    BONE MARROW TRANSPLANTATION, 2015, 50 (02) : 165 - 172
  • [26] Posaconazole: clinical pharmacokinetics and drug interactions
    Lipp, Hans-Peter
    MYCOSES, 2011, 54 : 32 - 38
  • [27] STEREOSELECTIVITY IN CLINICAL PHARMACOKINETICS AND DRUG DEVELOPMENT
    CAMPBELL, DB
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (02) : 109 - 125
  • [28] Pharmacokinetics of Pravastatin in Pediatric Dyslipidemia Patients: Clinical Impact of Genetic Variation on Statin Disposition
    Wagner, Jonathan
    Abdel-Rahman, Susan
    van Haandel, Leon
    Raghuveer, Geetha
    Kauffman, Ralph
    Leeder, J. Steven
    CIRCULATION, 2015, 132
  • [29] Phenotyping drug disposition in oncology
    Opdam, Frans L.
    Gelderblom, Hans
    Guchelaar, Henk-jan
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 715 - 725
  • [30] Integrated pharmacokinetics and pharmacodynamics in drug development
    Dingemanse, Jasper
    Appel-Dingemanse, Silke
    CLINICAL PHARMACOKINETICS, 2007, 46 (09) : 713 - 737